Stable Isotope Method to Assess Dietary Protein Quality

Biological Availability Clinical Trial

Official title:

A Dual Stable Isotope Method to Assess Dietary Protein Quality in Humans: Characterization of Intrinsically Labelled 15N Milk Protein as a Reference Protein

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02966704
• Other study ID #: NL56440.081.16
• Status: Completed
• Phase: N/A
• First received: January 8, 2016
• Last updated: December 13, 2017
• Start date: July 21, 2016
• Est. completion date: November 21, 2016

Study information

• Verified date: December 2017
• Source: Wageningen University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The evaluation of protein quality has been identified as the top priority question by the Food and Agricultural Organization (FAO) of the United Nations. However, the current available methods do not precisely estimate protein quality, or need invasive procedures. The proposed 'dual tracer approach' is a non-invasive method to evaluate protein quality in humans.

The present project characterizes the use of 15N-intrinsically-labelled milk protein as a reference-protein for development a non-invasive method that can be used to assess protein quality in human subjects

Description:

Rationale: The evaluation of protein quality has been identified as the top priority question by the Food and Agricultural Organization (FAO) of the United Nations. However, the current available methods do not precisely estimate protein quality, or need invasive procedures. The proposed 'dual tracer approach' is a minimal invasive method to evaluate protein quality in humans.

Objective: The present project characterizes the use of 15N-intrinsically-labelled milk protein as a reference-protein for development a minimal invasive method that can be used to assess protein quality in human subjects. For this purpose, our primary objectives are to define the digestive and metabolic behaviour and distribution of the 15N-intrinsically-labelled milk protein compared to the internal standard 13C-spirulina.

Study design: Randomized cross-over trial with two experimental meals. Study population:

Healthy male and female, age 18-35y Intervention (if applicable): On two separate test days, subjects will receive a semi liquid meal (pudding) divided in 9 portions, (meal 1: 27 En% Protein,10 En% fat, 62 En% carbohydrates; meal 2: 14 En% Protein,10 En% fat, 75 En% carbohydrates), with intrinsically labelled 15N protein powder. Furthermore, the meal will contain a trace amount of 13C-labelled algae protein as an internal standard. Meals will differ in the amount (e.g. 50g or 25g) of 15N-labelled milk protein.

Main study parameters/endpoints: The ratio of isotopic enrichment (15N/13C) of (total) amino acids of the test meal and the blood plasma as determined by (gas chromatography-) isotope ratio mass spectrometry ((GC)-IRMS).

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: A meal challenge with intrinsically labelled protein and addition of stable isotope tracer is frequently used in postprandial studies. Stable isotopes are naturally occurring isotopes and are not harmful for subjects, as there is no decay. Furthermore, placing venous catheters and blood sampling can occasionally cause a local haematoma or bruise and some participants may report pain or discomfort. Subjects have to come to the research facility three times, a screening visit of 1 hour, and 2 experimental days of 7 hours. Subjects will be financially compensated for participation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: November 21, 2016
• Est. primary completion date: November 21, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• Healthy

• Age: 20 - 35 y

• BMI: 18.5 - 25 kg/m2

• Stable dietary habits

• Veins suitable for cannulation (blood sampling)

Exclusion Criteria:

• Having a history of medical or surgical events that may significantly affect the study outcome

• Medical drug use accept incidental use of paracetamol

• (Chronic) disease which might influence the study outcomes e.g. diabetes mellitus or any other endocrine disorder, active cardiovascular disease, hepatic disease, renal disease, cancer

• Milk protein intolerance

• Alcohol consumption of >14 (women) or > 21 (men) units per week

• Drug abuse

• Moderate intense physical activity (exercise) for more than 5 hours/week

• Reported weight loss or weight gain of > 3 kg in the month prior to pre-study screening

• Reported slimming diet, or medically prescribed diet

• Having a habitual diet with a protein content of <10 En% > 30 En%

• Reported vegan or macrobiotic life-style

• Recent blood donation (<1 month prior to Day 01 of the study)

• Not willing to comply to the controlled dietary intervention guidelines

• Not willing or afraid to give up blood donation during the study

• Personnel of Wageningen University, department of Human Nutrition, their partner and their first and second degree relatives

• Current and within 1 month participation in other research from the Division of Human Nutrition

• Not having a general practitioner

Related Conditions & MeSH terms

• Biological Availability

Intervention

Dietary Supplement:
• intrinsically labeled milk protein

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Wageningen University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	ratio of isotopic enrichment		6 hours